Cisplatin/Paclitaxel/Tislelizumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of cisplatin, paclitaxel, and tislelizumab that may be used in the treatment of esophageal and esophagogastric junction cancers.

**Synonyms:** - Cisplatin-Paclitaxel-Tislelizumab - Cisplatin/Paclitaxel Plus Tislelizumab-jsgr - Cisplatin/Paclitaxel/Tevimbra - Cisplatin/Paclitaxel/Tislelizumab - Cisplatin/Paclitaxel/Tislelizumab-jsgr Regimen